Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mastocytosis, Systemic 2Leukemia, Mast-Cell 2Congenital Abnormalities 2Aggression 2Neoplasm, Residual 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1GATA2 Deficiency 1

Interventions

Cytarabine 7Daunorubicin 3Mitoxantrone 2Idarubicin 2Gemtuzumab 2Etoposide 2Clofarabine 2tipifarnib 1temsirolimus 1midostaurin 1etoposide phosphate 1eltrombopag 1dexamethasone acetate 1alvocidib 1aldesleukin 1Whole-Body Irradiation 1Proto-Oncogene Proteins c-kit 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1Lenalidomide 1Imatinib Mesylate 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Busulfan 1Bone Marrow Transplantation 1Biopsy 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Basophilic, Acute × midostaurin × Clear all
NCT00651261 2021-08-18

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
717 enrolled 14 charts
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡